COVID-19

News

US signs $1bn order for GSK, Vir's COVID-19 antibody

The US has made a sizeable order for GlaxoSmithKline and Vir Biotechnology's antibody-based COVID-19 treatment sotrovimab said to be worth approximately $1 billion.

News

Pfizer files oral COVID pill in US, signs access deal for 95...

Armed with impressive new data for its oral antiviral Paxlovid, Pfizer has filed for emergency use authorisation as a COVID-19 treatment in the US – and signed a deal to allow other manufac

News

FDA clears GE Healthcare AI algorithm for patient intubation

An artificial intelligence algorithm developed by GE Healthcare that helps with the placement of endotracheal tubes (ETTs) has been approved by the FDA.

News

scientifically visualization of a coronavirus spike protein

AI tool may help doctors select best drugs for COVID patient...

Researchers in the US have developed an artificial intelligence-based tool that is able to predict COVID-19 symptoms and suggest which FDA-approved drugs might be used to treat patients.

News

AstraZeneca will make 'modest' profit from COVID vaccine

AstraZeneca has said it plans to start making a small profit from sales of its COVID-19 vaccine Vaxzevria, which brought in just over $1 billion in sales in the third quarter, after selling

News

COVID antibodies from Roche, Celltrion backed for approval i...

The EMA's human medicines committee has recommended approval of Roche's Ronapreve and Celltrion's Regkirona for use in COVID-19, the first antibody-based therapies for coronavirus to be bac

US signs $1bn order for GSK, Vir's COVID-19 antibody

Pfizer files oral COVID pill in US, signs access deal for 95...

FDA clears GE Healthcare AI algorithm for patient intubation

AI tool may help doctors select best drugs for COVID patient...

AstraZeneca will make 'modest' profit from COVID vaccine

COVID antibodies from Roche, Celltrion backed for approval i...

NICE guidance calls for quicker diagnosis of PMOS

Discover a new era of healthcare panel engagement: Grounded ...

COVID-19

Editor's Picks